personal expenses and the depreciation because of the expanding capacity of subsidiaries. Sincerely yours, (Mr.Pongpat Patanavanich) Managing Director
Consolidated net loss for the period (Q1) amount -4.57 million compare with the same period (Q1) for the last year amount -2.80 because the Company Cost of Market Development of Expanding the customer base and
operations & Administrative expenses increased by Baht 97.94 million or 6.79 % due to the Medical personal expenses which was in line with the increased revenue,also increased because of the expanding capacity
& Administrative expenses increased by Baht 23.54 million or 13.02 % due to the Medical personal expenses also increased because of the expanding capacity of subsidiaries. 3. Finance costs increased by Baht 13.17
increased . 1.2 Cost of hospital operations increased by Baht 33.70 million or 7.89% mainly due to the Medical personal expenses also increased because of the expanding capacity of subsidiaries. 1.3 Selling
from Jan-2017. As a result, AIS has recognized the benefit totaling around Bt200mn fully in 4Q17, shown in the cost of regulatory fee. The new rates will continue and are below. Service revenue range (Bt
under construction. When the hemodialysis solution A and B was ready for sell in July 2017 (as shown in the table below), GWM gradually gained more revenue as a result and reach a profit increase of 11.56
medicines, expanding various product types, increasing revenue and reducing costs Agenda 4 To consider and approve the issuance and offering of debentures in an amount not exceeding 300 million Baht. The
cost was 126.3 MB decreased by 14.2 MB or 10.1% YoY. Because the Company is able to control the cost and labor cost more efficiently, which makes the gross profit increase compared to the previous year
for the 6-month period ended June 30, 2018. Net profit increase of Baht 47.63 million or 81.06% from the corresponding period of the previous year as the following details below: 1. Revenue from sales